Human NY-ESO-1 TCR Protein, Fc Tag (MALS & SPR verified)
Selected Variant
GTR19149928-01
Size: 25 µg
NY-ESO-1 is one of the most recognized tumor antigens in immunotherapy. Its expression is strictly limited to male germ cells and multiple malignant tumor cells, with virtually no presence in normal somatic cells. This unique expression profile makes it an ideal target for T-cell receptor (TCR) therapy. NY-ESO-1 specific TCR can bind to NY-ESO-1 peptides presented by MHC molecules, and clinical trials have demonstrated significant efficacy of NY-ESO-1 targeted TCR-T therapy in advanced sarcomas and other malignancies.
Product Specifications
Reactivity
Human
Conjugation
Unconjugated
Tag
C-Fc
Field of Research
Immunology & Inflammation; Metabolism Research
Endotoxin
1.0 EU per μg
Purity
90%
Form
Powder
Molecular Weight
49.3 kDa & 53.2 kDa
Storage Conditions
-20°C
Notes
For research use only.
Applications Notes
Preservative
50 mM Tris, 100 mM Glycine, 25 mM Arginine, 150 mM NaCl, pH 7.5
Available Sizes
Price
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Bcl-2 (Apoptosis & Follicular Lymphoma Marker) (BCL2/2210R), CF640R conjugate, 0.1mg/mL
Cytokeratin 18 (C-04), Biotin conjugate, 0.1mg/mL
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), 0.2mg/mL
